Department of Psychiatry Columbia University, College of P&S NYS Psychiatric Institute DDIIVVIISSIIOONN OOFF BBRRAAIINN SSTTIIMMUULLAATTIIOONN AANNDD TTHHEERRAAPPEEUUTTIICC MMOODDUULLAATTIIOONN SSPPEECCIIAALL LLEECCTTUURREE MMaaxx FFiinnkk,, MM..DD.. PPrrooffeessssoorr ooff PPssyycchhiiiaattrryy aanndd NNeeuurroollooggyy EEmmeerriiittuuss SSUUNNYY,,, SSttoonnyy BBrrooookk CCaattaattoonniiaa aanndd MMeellaanncchhoolliiaa:: RReessppoonnssiivvee ssyynnddrroommeess Wednesday October 22, 2008 12:00 PM to 1:00 PM Location: New York State Psychiatric Institute, 1051 Riverside Drive, Rm. 6601 (Board Room) (Enter Kolb Annex, 40 Haven Ave., turn rt., walk though atrium, across bridge over Riverside Dr. to new NYSPI, walk south along main corridor) (See over for speaker brief biography and J Club paper) About Max Fink, M.D. Dr. Max Fink is one of the world’s leading experts in Electroconvulsive Therapy (ECT). Since 1972, he has been at SUNY at Stony Brook, where he is Professor of Psychiatry and Neurology Emeritus. Since 1997, he has also been on the faculty at AECOM and the LIJ-Hillside Medical Center. Dr. Fink's studies of ECT began at Hillside Hospital in 1952, and he has published broadly on predictors of outcome in ECT, effects of seizures on EEG and speech, hypotheses of the mode of action, and how to achieve an effective treatment. In 1972, with Drs. Seymour Kety and James McGaugh, he organized an NIMH sponsored conference on the biology of convulsive therapy which resulted in the volume Psychobiology of Convulsive Therapy (1974). In 1979, he published the textbook Convulsive Therapy: Theory and Practice (Raven Press, 306 pp.). In 1984, he established CONVULSIVE THERAPY, a quarterly scientific journal (renamed Journal of ECT). From 1975 to 1978, and again from 1987 to 1990, he was a member of the Task Forces on Electroconvulsive Therapy of the American Psychiatric Association. In 1995-1996, he chaired the Task Force on Ambulatory ECT of the Association for Convulsive Therapy. In 1999, he published the trade book ELECTROSHOCK: Restoring the Mind (Oxford University Press, NY) that was re-issued in paperback in 2002. He has received many prize awards for his research in ECT and in EEG, including including the Electroshock Research Award (1956), the A.E. Bennnett award of the Society of Biological Psychiatry (1958), the Anna Monika Prize award for research into depressive illness (1979), the Laszlo Meduna Prize of the Hungarian National Institute for Nervous and Mental Disease (1986), the Gold Medal award of the Society of Biological Psychiatry (1988), and Lifetime Achievement Awards of the Psychiatric Times (1995) and of the Society of Biological Psychiatry (1996). In the past few years, Dr. Fink has been interested in catatonia and the neuroleptic malignant syndrome. In 2003, Catatonia: A Clinician's Guide to Diagnosis and Treatment, a joint effort with Prof Michael A. Taylor of University of Michigan, was published by Cambridge University Press. Another effort, Ethics of ECT, with Professor Jan-Otto Ottosson of the University of Göeborg, Sweden, will be published by Brunner-Routledge Publishing Group in 2004. He is now working on a book on Melancholia with Dr. Taylor, to be published by Cambridge University Press in 2005; and concurrently, on a History of Convulsive Therapy with the Toronto (Canada) Professor of History of Medicine, Edward Shorter and the Reader in Psychopharmacology David Healy of Wales UK. For Dr. Fink’s more complete biography and publications, go to http://www.hsc.stonybrook.edu/SOM/psychiatry/fink_m.cfm Selected Recent Publications Williams MD, Rummans T, Sampson S, Knapp R, Mueller M, Husain MM, Fink M, Rasmussen K, O'Connor K, Smith G, Petrides G, Kellner CH. Outcome of electroconvulsive therapy by race in the consortium for research on electroconvulsive therapy multisite study. J ECT. 2008 Jun;24(2):117-21. Fink M, Petrides G, Kellner C, Mueller M, Knapp R, Husain MM, Rasmussen K, Rummans T, O'Connor K; CORE Group. Change in seizure threshold during electroconvulsive therapy. J ECT. 2008 Jun;24(2):114-6. Sartorius N, Baghai TC, Baldwin DS, Barrett B, Brand U, Fleischhacker W, Goodwin G, Grunze H, Knapp M, Leonard BE, Lieberman J, Nakane Y, Pinder RM, Schatzberg AF, Svestka J, Baumann P, Ghalib K, Markowitz JC, Padberg F, Fink M, Furukawa T, Fountoulakis KN, Jensen P, Kanba S, Riecher-Rössler A. Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol. 2007 Dec;10 Suppl 1:S1-207. Review. No abstract available. Husain MM, McClintock SM, Rush AJ, Knapp RG, Fink M, Rummans TA, Rasmussen K, Claassen C, Petrides G, Biggs MM, Mueller M, Sampson S, Bailine SH, Lisanby SH, Kellner CH. The efficacy of acute electroconvulsive therapy in atypical depression. J Clin Psychiatry. 2008 Mar;69(3):406-11. Rasmussen KG, Knapp RG, Biggs MM, Smith GE, Rummans TA, Petrides G, Husain MM, O'Connor MK, Fink M, Kellner CH. Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial. J ECT. 2007 Dec;23(4):244-50. Rasmussen KG, Mueller M, Knapp RG, Husain MM, Rummans TA, Sampson SM, O'Connor MK, Petrides G, Fink M, Kellner CH. Antidepressant medication treatment failure does not predict lower remission with ECT for major depressive disorder: a report from the consortium for research in electroconvulsive therapy. J Clin Psychiatry. 2007 Nov;68(11):1701-6. Fink M, Rush AJ, Knapp R, Rasmussen K, Mueller M, Rummans TA, O'Connor K, Husain M, Biggs M, Bailine S, Kellner CH; Consortium for Research in ECT (CORE) Study Group. DSM melancholic features are unreliable predictors of ECT response: a CORE publication. J ECT. 2007 Sep;23(3):139-46. Taylor MA, Fink M. Restoring melancholia in the classification of mood disorders. J Affect Disord. 2008 Jan;105(1-3):1-14. Epub 2007 Jul 19. Review. http://www.brainstimulation.columbia.edu/ 2 .